LRCH1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.477200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.493800E-01
Normal-vs-Stage2
5.891200E-01
Normal-vs-Stage3
3.491000E-01
Normal-vs-Stage4
7.683000E-01
Stage1-vs-Stage2
7.624800E-01
Stage1-vs-Stage3
5.347200E-01
Stage1-vs-Stage4
4.604200E-01
Stage2-vs-Stage3
3.280600E-01
Stage2-vs-Stage4
3.116200E-01
Stage3-vs-Stage4
3.253000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.079400E-01
Normal-vs-AfricanAmerican
6.961600E-01
Normal-vs-Asian
5.955800E-01
Caucasian-vs-AfricanAmerican
8.010800E-01
Caucasian-vs-Asian
9.454800E-01
AfricanAmerican-vs-Asian
8.756800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.290600E-01
Normal-vs-Female
5.714600E-01
Male-vs-Female
6.720200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.166200E-01
Normal-vs-Age(41-60Yrs)
7.128400E-01
Normal-vs-Age(61-80Yrs)
4.830600E-01
Normal-vs-Age(81-100Yrs)
5.489400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.556600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.425600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.720600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.966210E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.153600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.277600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.951000E-01
Normal-vs-Daily Drinker
1.807760E-01
Normal-vs-Weekly Drinker
3.748000E-01
Normal-vs-Occasional Drinker
5.900600E-01
Normal-vs-Social Drinker
9.272800E-01
Non Drinker-vs-Daily Drinker
2.367400E-01
Non Drinker-vs-Weekly Drinker
7.800200E-01
Non Drinker-vs-Occasional Drinker
6.302600E-01
Non Drinker-vs-Social Drinker
1.975580E-01
Daily Drinker-vs-Weekly Drinker
4.898200E-01
Daily Drinker-vs-Occasional Drinker
1.504420E-01
Daily Drinker-vs-Social Drinker
4.029700E-02
Weekly Drinker-vs-Occasional Drinker
5.322800E-01
Weekly Drinker-vs-Social Drinker
2.166200E-01
Occasional Drinker-vs-Social Drinker
4.652600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.402180E-01
Normal-vs-Grade 2
8.882300E-03
Normal-vs-Grade 3
1.470090E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.229380E-01
Grade 1-vs-Grade 3
2.000400E-01
Grade 1-vs-Grade 4
1.402180E-01
Grade 2-vs-Grade 3
6.820400E-01
Grade 2-vs-Grade 4
8.882300E-03
Grade 3-vs-Grade 4
1.470090E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.223000E-01
Normal-vs-NonDiabetic
4.659800E-01
Diabetic-vs-NonDiabetic
6.673200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.704000E-01
Normal-vs-NoPancreatitis
4.524000E-01
Pancreatitis-vs-NoPancreatitis
8.990200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.602600E-01
Normal-vs-N1
6.103600E-01
N0-vs-N1
6.217600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.373600E-01
Normal-vs-TP53-NonMutant
3.188600E-01
TP53-Mutant-vs-TP53-NonMutant
4.885600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
